Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53. [electronic resource]
Producer: 20210405Description: 1086-1097 p. digitalISSN:- 1097-0215
- Animals
- Apoptosis -- drug effects
- Aza Compounds -- pharmacology
- Bridged Bicyclo Compounds, Heterocyclic -- pharmacology
- Cell Line, Tumor
- Chromans -- pharmacology
- Female
- HSP70 Heat-Shock Proteins -- antagonists & inhibitors
- Humans
- Maintenance Chemotherapy -- methods
- Mice, Nude
- Molecular Targeted Therapy -- methods
- Mutation
- Ovarian Neoplasms -- drug therapy
- Thiones -- pharmacology
- Tumor Suppressor Protein p53 -- antagonists & inhibitors
- Xenograft Model Antitumor Assays -- methods
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.